Patents by Inventor Wanwan S. Din

Wanwan S. Din has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of use of the TACI/TACI-L interaction
    Patent number: 8133976
    Abstract: The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: March 13, 2012
    Assignee: Immunex Corporation
    Inventors: Raymond G. Goodwin, Wanwan S. Din
  • METHODS OF USE OF THE TACI/TACI-L INTERACTION
    Publication number: 20100196404
    Abstract: The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed.
    Type: Application
    Filed: November 6, 2009
    Publication date: August 5, 2010
    Applicant: IMMUNEX CORPORATION
    Inventors: RAYMOND G. GOODWIN, WANWAN S. DIN
  • Methods of use of the TACI/TACI-L interaction
    Publication number: 20090081700
    Abstract: The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed.
    Type: Application
    Filed: July 23, 2008
    Publication date: March 26, 2009
    Applicant: Immunex Corporation
    Inventors: Raymond G. Goodwin, Wanwan S. Din
  • Methods of use of the TACI/TACI-L interaction
    Publication number: 20030165986
    Abstract: The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed.
    Type: Application
    Filed: May 14, 2001
    Publication date: September 4, 2003
    Applicant: Immunex Corporation
    Inventors: Raymond G. Goodwin, Wanwan S. Din
  • METHODS OF USE OF THE TACI/TACI-L INTERACTION
    Publication number: 20030022233
    Abstract: The invention discloses a novel interaction between a TNF receptor (TACI) and its interacting ligand (TACI-L). Also disclosed are methods of screening candidate molecules to determine potential antagonists and agonists of the TACI/TACI-L interaction. The use of the antagonists and agonists as therapeutics to treat autoimmune diseases, inflammation, and to inhibit graft vs. host rejections is further disclosed.
    Type: Application
    Filed: April 30, 1999
    Publication date: January 30, 2003
    Inventors: RAYMOND G. GOODWIN, WANWAN S. DIN